Results 131 to 140 of about 7,788 (207)

Optimization of 4-Amino-2-Pyridone Inhibitors of Proprotein Convertase Subtilisin/Kexin Type 9: Integrating Structure-Activity and Structure-Metabolism Relationships. [PDF]

ChemMedChem
Giannessi L, Lupo MG, Ugolotti M, Papotti B, Mattina B, Martina MG, Demurtas A, Padula C, Nicoli S, Crescenzio M, Ferri N, Zimetti F, Radi M.   +12 more
europepmc   +1 more source

Ischemic Colitis Following Baloxavir Marboxil Administration. [PDF]

Intern Med
Tanaka S.
europepmc   +1 more source

Regiocontrollable [2 + 2] benzannulation of γ,δ-C(sp3)-H bonds with dihaloarenes using palladium catalysis. [PDF]

Nat Synth
Hu L, Yan JL, Lin YK, Strassfeld DA, Yu JQ.   +4 more
europepmc   +1 more source

2-Pyridone-assisted palladium-catalyzed regioselective arylation of naphthamides. [PDF]

RSC Adv
Prajapati J, Chatterjee S.
europepmc   +1 more source

Eco-Friendly Spectrofluorimetric Determination of Apixaban Using SDS-Enhanced Fluorescence in Pharmaceutical Forms and Plasma. [PDF]

Luminescence
Halim ME, Nagy DM, Derayea SM.
europepmc   +1 more source

Crystal structure, spectroscopy, DFT, and thermal studies of 3-cyano-2(1H)-pyridones as potential anticancer agents. [PDF]

RSC Adv
Hurtado-Rodríguez D, Becerra D, Rojas H, Gómez Castaño JA, Macías MA, Castillo JC.   +5 more
europepmc   +1 more source

Epidemiologic Impact of Prioritizing Long-Acting Injectable Cabotegravir to Men Who Have Sex With Men With Low Pre-Exposure Prophylaxis Use Adherence in the Netherlands: A Mathematical Modeling Study. [PDF]

J Acquir Immune Defic Syndr
Wang H, Jonas KJ, van de Vijver D.
europepmc   +1 more source

Long-Acting Injectable Cabotegravir HIV PrEP Uptake, Adherence, and Persistence in Two Large US Integrated Healthcare Systems. [PDF]

J Acquir Immune Defic Syndr
Traeger MW, Traeger MW, Leyden WA, Eberhart LG, Volk JE, Silverberg MJ, Horberg MA, Davis TL, Mayer KH, Krakower DS, Young JG, Jenness SM, Marcus JL.   +12 more
europepmc   +1 more source

Long-term persistence, effectiveness, safety, and metabolic impact of bictegravir/emtricitabine/tenofovir alafenamide fixed-dose combination in people living with HIV in the BICTARG cohort. [PDF]

Rev Esp Quimioter
Cecchini D, Brizuela M, Copertari G, Bacelar B, Lamaizon C, Roel M, Bottaro E, Cassetti I.   +7 more
europepmc   +1 more source

Excessive Apixaban Concentrations in a Bleeding Patient Treated With Pharmacological Reversal and Extracorporal Removal-A Case Report. [PDF]

Pharmacol Res Perspect
Kraus RF, Rosenberger J, Dejaco A, Paal M, Hart C, Burkhardt R, Kees MG.   +6 more
europepmc   +1 more source